Literature DB >> 24756451

Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer.

Marianne Schmid1, Shahrokh F Shariat, Armin Soave, Oliver Engel, Margit Fisch, Michael Rink.   

Abstract

In 2008, urothelial carcinoma of the bladder (UCB) was the 8th most common cause of death in Germany. An increasing body of evidence suggests differences in the presentation and prognosis of UCB between genders. Large population-based and multi-institutional studies have found a higher incidence of UCB in men, while women treated with radical cystectomy (RC) have shown unfavorable outcomes compared to their male counterparts. Indeed, it is important to note that UCB incidence and outcomes have regional and country-specific variability. These distinct country and gender-specific differences must be considered in patient counseling, treatment decisions, and UCB management. This review summarizes the contemporary literature regarding the impact of gender on UCB outcomes, focusing on patients treated with RC in Germany. We evaluated the most current literature regarding gender-specific differences in UCB incidence, treatment patterns, and oncological outcomes, including pathological stage distribution and survival.

Entities:  

Mesh:

Year:  2014        PMID: 24756451     DOI: 10.1007/s11934-014-0409-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  67 in total

Review 1.  Biomolecular predictors of urothelial cancer behavior and treatment outcomes.

Authors:  Michael Rink; Eugene K Cha; David Green; Jens Hansen; Brian D Robinson; Yair Lotan; Arthur I Sagalowsky; Felix K Chun; Pierre I Karakiewicz; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

2.  Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.

Authors:  Derya Tilki; Robert S Svatek; Giacomo Novara; Michael Seitz; Guilherme Godoy; Pierre I Karakiewicz; Wassim Kassouf; Yves Fradet; Hans-Martin Fritsche; Guru Sonpavde; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Mark Schoenberg; Christian G Stief; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Oliver Reich; Shahrokh F Shariat
Journal:  J Urol       Date:  2010-09       Impact factor: 7.450

3.  Gender-dependent cancer-specific survival following radical cystectomy.

Authors:  Matthias May; Christian Stief; Sabine Brookman-May; Wolfgang Otto; Christian Gilfrich; Jan Roigas; Mario Zacharias; Wolf F Wieland; Hans-Martin Fritsche; Ferdinand Hofstädter; Maximilian Burger
Journal:  World J Urol       Date:  2011-10-09       Impact factor: 4.226

4.  Sex differences in incidence and mortality of bladder and kidney cancers: national estimates from 49 countries.

Authors:  Heather Donsky; Sean Coyle; Emil Scosyrev; Edward M Messing
Journal:  Urol Oncol       Date:  2013-07-04       Impact factor: 3.498

Review 5.  Epidemiology and risk factors of urothelial bladder cancer.

Authors:  Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan
Journal:  Eur Urol       Date:  2012-07-25       Impact factor: 20.096

6.  Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology.

Authors:  Timothy Siegrist; Caroline Savage; Ahmad Shabsigh; Angel Cronin; S Machele Donat
Journal:  Urol Oncol       Date:  2010 Jan-Feb       Impact factor: 3.498

7.  National and international variation in the registration of bladder cancer.

Authors:  P Crow; A W S Ritchie
Journal:  BJU Int       Date:  2003-10       Impact factor: 5.588

8.  Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.

Authors:  Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Hendrik Isbarn; Oliver Reich; Wassim Kassouf; Yves Fradet; Giacomo Novara; Hans-Martin Fritsche; Patrick J Bastian; Jonathan I Izawa; Christian G Stief; Vincenzo Ficarra; Seth P Lerner; Mark Schoenberg; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Journal:  J Urol       Date:  2010-01       Impact factor: 7.450

Review 9.  Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity.

Authors:  Georgios Gakis; Arnulf Stenzl
Journal:  World J Urol       Date:  2013-02-09       Impact factor: 4.226

10.  Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.

Authors:  A Buchner; M May; M Burger; C Bolenz; E Herrmann; H-M Fritsche; J Ellinger; T Höfner; P Nuhn; C Gratzke; S Brookman-May; S Melchior; J Peter; R Moritz; D Tilki; C Gilfrich; J Roigas; M Zacharias; M Hohenfellner; A Haferkamp; L Trojan; W F Wieland; S C Müller; C G Stief; P J Bastian
Journal:  Eur J Surg Oncol       Date:  2013-04       Impact factor: 4.424

View more
  4 in total

1.  Determining If Sex Bias Exists in Human Surgical Clinical Research.

Authors:  Neel A Mansukhani; Dustin Y Yoon; Katherine A Teter; Vanessa C Stubbs; Irene B Helenowski; Teresa K Woodruff; Melina R Kibbe
Journal:  JAMA Surg       Date:  2016-11-01       Impact factor: 14.766

Review 2.  Female with bladder cancer: what and why is there a difference?

Authors:  Phillip Marks; Armin Soave; Shahrokh F Shariat; Harun Fajkovic; Margit Fisch; Michael Rink
Journal:  Transl Androl Urol       Date:  2016-10

3.  Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies.

Authors:  Hiroki Ide; Satoshi Inoue; Hiroshi Miyamoto
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

Review 4.  Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor.

Authors:  Hiroki Ide; Hiroshi Miyamoto
Journal:  Dis Markers       Date:  2015-12-07       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.